Correlation Between Deciphera Pharmaceuticals and Takeda Pharmaceutical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Deciphera Pharmaceuticals and Takeda Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Deciphera Pharmaceuticals and Takeda Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Deciphera Pharmaceuticals LLC and Takeda Pharmaceutical Co, you can compare the effects of market volatilities on Deciphera Pharmaceuticals and Takeda Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Deciphera Pharmaceuticals with a short position of Takeda Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Deciphera Pharmaceuticals and Takeda Pharmaceutical.

Diversification Opportunities for Deciphera Pharmaceuticals and Takeda Pharmaceutical

0.22
  Correlation Coefficient

Modest diversification

The 3 months correlation between Deciphera and Takeda is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Deciphera Pharmaceuticals LLC and Takeda Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Takeda Pharmaceutical and Deciphera Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Deciphera Pharmaceuticals LLC are associated (or correlated) with Takeda Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Takeda Pharmaceutical has no effect on the direction of Deciphera Pharmaceuticals i.e., Deciphera Pharmaceuticals and Takeda Pharmaceutical go up and down completely randomly.

Pair Corralation between Deciphera Pharmaceuticals and Takeda Pharmaceutical

Given the investment horizon of 90 days Deciphera Pharmaceuticals LLC is expected to under-perform the Takeda Pharmaceutical. In addition to that, Deciphera Pharmaceuticals is 3.04 times more volatile than Takeda Pharmaceutical Co. It trades about -0.02 of its total potential returns per unit of risk. Takeda Pharmaceutical Co is currently generating about 0.0 per unit of volatility. If you would invest  1,418  in Takeda Pharmaceutical Co on September 4, 2024 and sell it today you would lose (32.00) from holding Takeda Pharmaceutical Co or give up 2.26% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy30.71%
ValuesDaily Returns

Deciphera Pharmaceuticals LLC  vs.  Takeda Pharmaceutical Co

 Performance 
       Timeline  
Deciphera Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Deciphera Pharmaceuticals LLC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Deciphera Pharmaceuticals is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.
Takeda Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Takeda Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Takeda Pharmaceutical is not utilizing all of its potentials. The newest stock price mess, may contribute to short-term losses for the institutional investors.

Deciphera Pharmaceuticals and Takeda Pharmaceutical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Deciphera Pharmaceuticals and Takeda Pharmaceutical

The main advantage of trading using opposite Deciphera Pharmaceuticals and Takeda Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Deciphera Pharmaceuticals position performs unexpectedly, Takeda Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Takeda Pharmaceutical will offset losses from the drop in Takeda Pharmaceutical's long position.
The idea behind Deciphera Pharmaceuticals LLC and Takeda Pharmaceutical Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments